Vice President Governance @ (May 2024 - April 2025)
Chairman of the Board @ (February 2021 - Present)
Chairman of the Board @ (January 2021 - Present)
Chief Executive Officer and Managing Director @ (January 2021 - April 2024)
Vice President Governance @ (January 2020 - July 2022)
Chief Executive Officer and Managing Director @ Emavant Solutions (January 2018 - December 2019)
Global Business Franchise Head Cardio-Metabolic Medicines @ (October 2014 - December 2017)
Global Business Franchise Head Ophthalmics @ (April 2013 - September 2014)
Head Pharma and President Novartis Taiwan @ (April 2011 - March 2013)
Head Marketing and Sales Region AMAC (Asia-Pacific, Middle East and African Countries) @ (March 2009 - March 2011)
Global Brand Head Rasilez and Tekturna @ (July 2007 - February 2009)
Business Franchise Head Cardiovascular and Metabolism in Germany @ (October 2006 - June 2007)
Leadership Development Program (Sales Rotation in Germany) @ (November 2005 - September 2006)
Global Head New Products and Portfolio Strategy @ (April 2005 - October 2005)
Global Disease Area Strategy Director @ (June 2003 - March 2005)
Engagement Manager in Frankfurt Office, Germany @ (September 1999 - May 2003)
Head of Biochemistry @ Hoechst Roussel Vet GmbH (now part of MSD Animal Health) (March 1998 - August 1999)
Markus Rohrwild Education
Harvard Medical School
PhD (Biological and Biomedical Sciences)
1994-1998
University of Applied Sciences Weihenstephan-Triesdorf
Dipl. Ing. FH (Biotechnology)
1989-1994
Markus Rohrwild Summary
Markus Rohrwild, based in Denmark, is currently a Chief Executive Officer at Gubra. Markus Rohrwild brings experience from previous roles at Roivant Sciences, Roivant, Genevant Sciences and Affivant. Markus Rohrwild holds a 1994 - 1998 PhD in Biological and Biomedical Sciences @ Harvard Medical School. Markus Rohrwild has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Markus Rohrwild?
Find contact details for 700 million professionals.